Marwan Sabbagh

7.5k total citations · 2 hit papers
14 papers, 3.7k citations indexed

About

Marwan Sabbagh is a scholar working on Physiology, Pharmacology and Neurology. According to data from OpenAlex, Marwan Sabbagh has authored 14 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 3 papers in Pharmacology and 3 papers in Neurology. Recurrent topics in Marwan Sabbagh's work include Alzheimer's disease research and treatments (7 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Dementia and Cognitive Impairment Research (2 papers). Marwan Sabbagh is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Dementia and Cognitive Impairment Research (2 papers). Marwan Sabbagh collaborates with scholars based in United States, United Kingdom and Spain. Marwan Sabbagh's co-authors include Shobha Dhadda, Michael C. Irizarry, Lynn D. Kramer, Chad J. Swanson, Michio Kanekiyo, Larisa Reyderman, David Watson, Randall J. Bateman, Sharon Cohen and Takeshi Iwatsubo and has published in prestigious journals such as New England Journal of Medicine, Movement Disorders and Drugs.

In The Last Decade

Marwan Sabbagh

12 papers receiving 3.6k citations

Hit Papers

Lecanemab in Early Alzheimer’s Di... 2016 2026 2019 2022 2022 2016 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Lecanemab in Early Alzheimer’s Disease
    2022 2.7k citations Christopher H. van Dyck, Chad J. Swanson et al. New England Journal of Medicine profile →
  2. The Impact of Mild Cognitive Impairment on Gait and Balance: A Systematic Review and Meta-Analysis of Studies Using Instrumented Assessment
    2016 289 citations Bijan Najafi, Ahlam Saleh et al. Gerontology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marwan Sabbagh United States 9 1.9k 1.2k 731 687 536 14 3.7k
Lutz Froelich Germany 19 1.9k 1.0× 1.4k 1.2× 777 1.1× 658 1.0× 569 1.1× 54 3.9k
Michio Kanekiyo United States 12 1.8k 1.0× 1.1k 0.9× 707 1.0× 538 0.8× 534 1.0× 28 3.3k
Michelle Gee United Kingdom 17 1.7k 0.9× 1.3k 1.1× 763 1.0× 504 0.7× 554 1.0× 26 3.8k
Ara S. Khachaturian United States 25 1.8k 0.9× 1.4k 1.2× 733 1.0× 627 0.9× 863 1.6× 51 4.3k
Larisa Reyderman United States 24 2.2k 1.2× 1.2k 1.0× 1.2k 1.7× 623 0.9× 817 1.5× 107 5.2k
Ronald S. Black United States 22 2.4k 1.3× 1.1k 0.9× 609 0.8× 715 1.0× 686 1.3× 46 3.3k
Chen‐Chen Tan China 31 1.6k 0.8× 1.4k 1.2× 1.0k 1.4× 820 1.2× 412 0.8× 115 4.6k
Michael S. Rafii United States 33 1.7k 0.9× 1.3k 1.1× 979 1.3× 599 0.9× 470 0.9× 112 4.8k
Simone Lista France 40 2.5k 1.3× 1.6k 1.3× 1.4k 1.9× 771 1.1× 392 0.7× 126 4.7k
Vitaliy Ovod United States 19 2.9k 1.5× 1.5k 1.2× 940 1.3× 950 1.4× 379 0.7× 26 4.2k

Countries citing papers authored by Marwan Sabbagh

Since Specialization
Citations

This map shows the geographic impact of Marwan Sabbagh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marwan Sabbagh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marwan Sabbagh more than expected).

Fields of papers citing papers by Marwan Sabbagh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marwan Sabbagh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marwan Sabbagh. The network helps show where Marwan Sabbagh may publish in the future.

Co-authorship network of co-authors of Marwan Sabbagh

This figure shows the co-authorship network connecting the top 25 collaborators of Marwan Sabbagh. A scholar is included among the top collaborators of Marwan Sabbagh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marwan Sabbagh. Marwan Sabbagh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Abushakra, Susan, Anton P. Porsteinsson, Marwan Sabbagh, et al.. (2024). APOLLOE4 Phase 3 study of oral ALZ‐801/valiltramiprosate in APOE ε4/ε4 homozygotes with early Alzheimer's disease: Trial design and baseline characteristics. Alzheimer s & Dementia Translational Research & Clinical Interventions. 10(3). e12498–e12498. 10 indexed citations
3.
Honig, Lawrence S., Jerome Barakos, Shobha Dhadda, et al.. (2023). ARIA in patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer's disease. Alzheimer s & Dementia Translational Research & Clinical Interventions. 9(1). e12377–e12377. 68 indexed citations
4.
Dyck, Christopher H. van, Chad J. Swanson, Paul Aisen, et al.. (2022). Lecanemab in Early Alzheimer’s Disease. New England Journal of Medicine. 388(1). 9–21. 2741 indexed citations breakdown →
5.
Najafi, Bijan, Ahlam Saleh, Marwan Sabbagh, et al.. (2016). The Impact of Mild Cognitive Impairment on Gait and Balance: A Systematic Review and Meta-Analysis of Studies Using Instrumented Assessment. Gerontology. 63(1). 67–83. 289 indexed citations breakdown →
6.
Chong, Catherine D., Jiong Shi, Marwan Sabbagh, et al.. (2013). P2–144: Age‐related frontal lobe compensation during novelty detection. Alzheimer s & Dementia. 9(4S_Part_10). 1 indexed citations
7.
8.
Breitner, John C.S., Laura D. Baker, Thomas J. Montine, et al.. (2011). Extended results of the Alzheimer's disease anti‐inflammatory prevention trial. Alzheimer s & Dementia. 7(4). 402–411. 276 indexed citations
9.
Sabbagh, Marwan, Sandra A. Jacobson, Jatin J. Shah, et al.. (2011). P4‐435: A pilot phase IV open label study investigating the safety and tolerability of switching from the Exelon patch 9.5mg daily to Aricept 23mg daily in patients with moderate to severe AD. Alzheimer s & Dementia. 7(4S_Part_25). 1 indexed citations
10.
Driver‐Dunckley, Erika, Donald J. Connor, Marwan Sabbagh, et al.. (2009). No evidence for cognitive dysfunction or depression in patients with mild restless legs syndrome. Movement Disorders. 24(12). 1843–1847. 65 indexed citations
11.
Sparks, David L., Richard J. Kryscio, Marwan Sabbagh, et al.. (2008). Reduced Risk of Incident AD with Elective Statin Use in a Clinical Trial Cohort. Current Alzheimer Research. 5(4). 416–421. 110 indexed citations
12.
Sparks, David L., Marwan Sabbagh, Donald J. Connor, et al.. (2006). Statin therapy in Alzheimer's disease. Acta Neurologica Scandinavica. 114(s185). 78–86. 85 indexed citations
13.
Sparks, David L., Marwan Sabbagh, Donald J. Connor, et al.. (2005). Atorvastatin Therapy Lowers Circulating Cholesterol but not Free Radical Activity in Advance of Identifiable Clinical Benefit in the Treatment of Mild-to-Moderate AD. Current Alzheimer Research. 2(3). 343–353. 58 indexed citations
14.
Tognellini, Rita, et al.. (1997). Apoptosis induced in glioma rat cells cultivated in the presence of a medicinal infusion of green tea.. PubMed. 41 Suppl 2. 85–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lutz Froelich Breakdown of academic impact, for papers by Michio Kanekiyo Breakdown of academic impact, for papers by Michelle Gee Breakdown of academic impact, for papers by Ara S. Khachaturian Breakdown of academic impact, for papers by Larisa Reyderman Breakdown of academic impact, for papers by Ronald S. Black Breakdown of academic impact, for papers by Chen‐Chen Tan Breakdown of academic impact, for papers by Michael S. Rafii Breakdown of academic impact, for papers by Simone Lista Breakdown of academic impact, for papers by Vitaliy Ovod
Rankless by CCL
2026